Bacopa Extract 320 mg
Goals
$28.55 $0.23 per serving
Product analysis
Bacopa Extract 320 mg may support selected memory skills with repeated use. The findings depend on the particular extract and do not establish a quick or universal improvement.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The bacoside description identifies part of the extract, but does not by itself confirm its preparation quality. Results from one extract cannot automatically be applied to every bacopa preparation.
Ingredient Transparency100
The extract amount and bacoside form are identified. That helps you compare the preparation rather than relying on the bacopa name alone.
Value For Money100
The serving price offers favorable value for the extract. Its low cost does not make uncertain memory or stress effects more predictable.
Customer Satisfaction87
Customers generally give positive ratings, backed by thousands of opinions. Those ratings describe satisfaction without establishing effectiveness or safety.
Product Focus55
A single extract keeps the memory-related purpose clear. Wider brain and stress benefits are less certain and depend on the preparation.
- Format
Capsule - Container
- 120 Capsule(s)
- Per serving
- $0.23
- Also available
Bacopa Extract 320 mg$9.00- Customer rating
- 4.7 · 3,542 ratings
Goals
Impact
Lower effect
Impact
Moderate effect
Bacopa extract may help with stress or anxiety, but the effect is uncertain and varies between preparations. That distinction matters here because the connection concerns an identified extract, rather than any bacopa powder or interchangeable extract. You shouldn't assume that the amount alone predicts how much calmer you'll feel.
How this product is rated for Stress Relief
Ingredient fit93
The identified bacopa extract relates to stress and anxiety, with uncertain effects.
Goal fit
The identified bacopa extract relates to stress and anxiety, with uncertain effects.
Dose adequacy
The serving supplies 320 mg identified bacopa extract, above the 300 mg lower comparison reference; that reference isn't a guarantee of benefit.
Pathways46
Bacopa's main connection concerns stress and anxiety through mood-related processes, with narrower applicability elsewhere.
Depth
Bacopa's main connection concerns stress and anxiety through mood-related processes, with narrower applicability elsewhere.
Breadth
Bacopa's main connection concerns stress and anxiety through mood-related processes, with narrower applicability elsewhere.
Evidence56
Bacopa's stress and anxiety effects are inconsistent and depend on the extract.
Evidence strength
Bacopa's stress and anxiety effects are inconsistent and depend on the extract.
Studied preparation
The connection applies to the identified bacopa extract; other extracts aren't interchangeable.
Formulation logic100
The relevant ingredients don't require an additional partner for their individual roles. No particular ingredient conflict is identified.
Partner coverage
The relevant ingredients can contribute individually without an additional required partner.
Conflicts
No particular conflict between the ingredients is identified.
Effective doses
The serving supplies 320 mg identified bacopa extract, above the 300 mg lower comparison reference; that reference isn't a guarantee of benefit.
Impact
Moderate effect
Bacopa · 320 mg
Bacopa at 320 mg has a modest link to memory and learning, alongside antioxidant-related and acetylcholine-related activity. The saved assessment finds adequate dose support but does not match the Synapsa preparation to the reviewed trials.
How this product is rated for Brain Health
Ingredient fit93
The assessed active ingredient is closely focused on brain health, although it is also linked to other goals. The assessed ingredient amounts meet the saved dose targets.
Goal fit
The assessed active ingredient is closely focused on brain health, although it is also linked to other goals.
Dose adequacy
The assessed ingredient amounts meet the saved dose targets.
Pathways40
The strongest assessed connection is oxidative and inflammatory protection, with moderate coverage. One assessed pathway reaches substantial coverage; the overall range remains narrow.
Depth
The strongest assessed connection is oxidative and inflammatory protection, with moderate coverage.
Breadth
One assessed pathway reaches substantial coverage; the overall range remains narrow.
Evidence27
Bacopa provides the strongest effective-dose evidence in the saved findings, with limits on broader brain-health conclusions. The assessed preparations are not matched to the reviewed trials in the saved findings.
Evidence strength
Bacopa provides the strongest effective-dose evidence in the saved findings, with limits on broader brain-health conclusions.
Studied preparation
The assessed preparations are not matched to the reviewed trials in the saved findings.
Formulation logic100
The assessed ingredients can contribute alone or have their required partner. No configured ingredient conflict was identified. 1 of 1 assessed ingredients reach the saved minimum dose threshold.
Partner coverage
The assessed ingredients can contribute alone or have their required partner.
Conflicts
No configured ingredient conflict was identified.
Effective doses
1 of 1 assessed ingredients reach the saved minimum dose threshold.
Impact
High effect
Bacopa · 320 mg
Synapsa bacopa has preparation-specific evidence for selected memory and working-memory outcomes after repeated use. The 320 mg serving matches the corrected daily exposure in the supplied 90-day healthy-adult trial. Substantial trial attrition limits confidence, and the findings do not establish immediate or universal cognitive improvement.
How this product is rated for Cognitive Support
Ingredient fit93
The identified Synapsa preparation supplies the product's cognitive connection.
Goal fit
The identified Synapsa preparation supplies the product's cognitive connection.
Dose adequacy
The 320 mg serving matches the corrected studied daily exposure.
Pathways56
Oxidative and inflammatory protection is the strongest pathway in the saved findings.
Depth
Oxidative and inflammatory protection is the strongest pathway in the saved findings.
Breadth
Only that pathway reaches the saved breadth threshold.
Evidence78
Synapsa has preparation-specific repeated-use findings, with substantial attrition limiting confidence.
Evidence strength
Synapsa has preparation-specific repeated-use findings, with substantial attrition limiting confidence.
Studied preparation
The saved findings recognize the included preparations; this does not remove the ingredient-specific limits on cognitive benefit.
Formulation logic100
The included ingredients require no missing partner, and no configured conflict was found.
Partner coverage
No required partner is missing for the included ingredients; this does not imply added benefit from combining them.
Conflicts
No configured ingredient conflict was found in the supplied facts.
Effective doses
All included ingredients meet the saved minimum amount threshold; that threshold is not proof of cognitive benefit.
Impact
Lower effect
Impact
Lower effect
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Bacopa Whole Plant Extract (Bacosides) | 320 mg |
Bacopa (Bacosides) · 320 mg OverallScore100
Each serving lists 320 mg of bacopa extract. The extract is recorded as 55% bacosides.
How this ingredient is rated
Composition and Label Disclosure
The saved facts identify the ingredient as bacopa extract.
Composition and Label Disclosure100
The 320 mg of bacopa extract is individually disclosed. The extract is recorded as 55% bacosides.
Amount and Label Disclosure
The 320 mg of bacopa extract is individually disclosed. The extract is recorded as 55% bacosides.
Commercial Price and Usability100
The whole-product price is about $0.24 per serving.
Commercial Price per Labeled Serving
The whole-product price is about $0.24 per serving.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
- Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.
- Comparative efficacy of Medhya Rasayana,Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8-10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial.
- Plant-derived nootropics and human cognition: A systematic review.
- The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials.
- The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials.
- A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations.
- Efficacy of Standardized Extract of Bacopa monnieri (Bacognize®) on Cognitive Functions of Medical Students: A Six-Week, Randomized Placebo-Controlled Trial.
- Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial.
- Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes.
- Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review.
- The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
- Effects of Bacopa monnieri (CDRI 08®) in a population of males exhibiting inattention and hyperactivity aged 6 to 14 years: A randomized, double-blind, placebo-controlled trial.
- The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects.
- Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.
- Brahmi for the better? New findings challenging cognition and anti-anxiety effects of Brahmi (Bacopa monniera) in healthy adults.
- Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial.
- An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance.
- Efficacy of Brahmi vati in generalised anxiety disorder - Randomized double blind comparative clinical trial.
- An acute, double-blind, placebo-controlled cross-over study of 320 mg and 640 mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood.